Tetrakis (4-carboxyphenyl) porphyrin
(Synonyms: 中-四(4-羧基苯基)卟吩; TCPP) 目录号 : GC61706
Tetrakis(4-carboxyphenyl)porphyrin(TCPP)可作为金属去除剂。
Cas No.:14609-54-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >97.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Tetrakis (4-carboxyphenyl) porphyrin (TCPP) plays the role of a metal remover[1].
[1]. Eun-Young Jeong, et al. Removal of Cu(II) from water by tetrakis(4-carboxyphenyl) porphyrin-functionalized mesoporous silica. J Hazard Mater. 2011 Jan 30;185(2-3):1311-7.
| Cas No. | 14609-54-2 | SDF | |
| 别名 | 中-四(4-羧基苯基)卟吩; TCPP | ||
| Canonical SMILES | O=C(O)C1=CC=C(/C2=C3C=CC(/C(C4=CC=C(C=C4)C(O)=O)=C5C=C/C(N/5)=C(C6=CC=C(C=C6)C(O)=O)/C(C=C/7)=NC7=C(C8=CC=C(C=C8)C(O)=O)/C9=CC=C2N9)=N\3)C=C1 | ||
| 分子式 | C48H30N4O8 | 分子量 | 790.79 |
| 溶解度 | DMSO : 4 mg/mL (5.06 mM; ultrasonic and warming and heat to 60°C) | 储存条件 | 4°C, protect from light, stored under nitrogen |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 1.2646 mL | 6.3228 mL | 12.6456 mL |
| 5 mM | 0.2529 mL | 1.2646 mL | 2.5291 mL |
| 10 mM | 0.1265 mL | 0.6323 mL | 1.2646 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework
Biomaterials 2022 Apr;283:121449.PMID:35247637DOI:10.1016/j.biomaterials.2022.121449.
Designing and developing nanomedicine based on the tumor microenvironment (TME) for effective cancer treatment is highly desirable. In this work, polyvinyl pyrrolidone (PVP) dispersed nanoscale metal-organic framework (NMOF) of Fe-TCPP (TCPP = Tetrakis (4-carboxyphenyl) porphyrin) loaded with hypoxia-activable prodrug tirapazamine (TPZ) and coated by the cancer cell membrane (CM) is constructed (the formed nanocomposite denoted as PFTT@CM). Due to the functionalization with the homologous cancer cell membrane, PFTT@CM is camouflaged to evade the immune clearance and preferentially accumulates at the tumor site. Once internalized by cancer cells, PFTT@CM is activated by the TME through redox reaction and Fenton reaction between Fe3+ in nano-platform and endogenous glutathione (GSH) and hydrogen peroxide (H2O2) to promote GSH exhausting as well as •OH and O2 production, which triggers ferroptosis and dramatically enhances photodynamic therapy (PDT) efficacy. Subsequently, the PDT process mediated by TCPP and light would consume oxygen and aggravate tumor hypoxia to further activate the prodrug TPZ for cancer chemotherapy. As a consequence, the TME-driven PFTT@CM nano-platform not only demonstrated its TME modulation ability but also showed a sequential synergistic therapy, which eventually inhibited the cancer cell proliferation. This multimodal nano-platform is expected to shed light on the design of TME-activatable reaction to reinforce the synergistic therapeutic outcome and facilitate the development of effective cancer nanomedicine.
A large π-conjugated Tetrakis (4-carboxyphenyl) porphyrin anode enables high specific capacity and superior cycling stability in lithium-ion batteries
Chem Commun (Camb) 2019 Sep 19;55(76):11370-11373.PMID:31478549DOI:10.1039/c9cc05474j.
We demonstrated a novel single molecule - tetrakis(4-carboxyphenyl) porphyrin (TCPP) with a large π-conjugated system as a high-performance organic anode of lithium batteries. It was found that this TCPP displayed relatively low solubility (<0.1 mg mL-1) in a 1 M LiDFOB/PC electrolyte, high reversible specific capacity (ca. 1200 mA h g-1 at 358 mA g-1), excellent rate capability (548.4 mA h g-1 at 8 A g-1) and superior cycling performance (capacity retention of 89% after 2500 cycles at 6 A g-1).
Transformation of H-Aggregates and J-Dimers of Water-Soluble Tetrakis (4-carboxyphenyl) porphyrin in Polyion Complex Micelles
Polymers (Basel) 2018 May 3;10(5):494.PMID:30966528DOI:10.3390/polym10050494.
Tetrakis (4-carboxyphenyl) porphyrin (TCPP) and polyelectrolyte poly(N-methyl-2-vinylpyridinium iodide)-b-poly(ethylene oxide) (PMVP41-b-PEO205) can self-aggregate into polyion complex (PIC) micelles in alkaline aqueous solution. UV-vis spectroscopy, fluorescence spectroscopy, transmission electron microscope, and dynamic light scattering were carried out to study PIC micelles. Density functional theory (DFT) calculation method was applied to study the interaction of TCPP and PMVP41-b-PEO205. We found that the H-aggregates and J-dimers of anionic TCPP transformed in PIC micelles. H-aggregates of TCPP formed at the charge ratio of TCPP/PMVP41-b-PEO205 1:2 and J-dimer species at the charge ratio above 1:4, respectively. It is worth noting that the transformation from H-aggregates to J-dimer species of TCPP occurred just by adjusting the ratio of polymer and TCPP rather than by changing other factors such as pH, temperature, and ions.